person · Reporting owner
van Gunsteren Job Leonard
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BALCHEM CORPBCPC · Entity 3839 | SVP and GM, Specialty Products | February 11, 2026 | February 14, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BALCHEM CORP
Report date February 11, 2026 · Filed February 14, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 10,149 |
Ending reported balance
After 2026-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-11 · Grant · Acquired 430 · Balance 9,618 F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Row 2 · 2026-02-11 · Grant · Acquired 1,345 · Balance 10,963 F2: Represents the vesting of performance stock units (includes 22 dividend equivalent shares) for the 2023-2025 performance period. Row 3 · 2026-02-11 · Tax withholding · Disposed 756 · Balance 10,207 F3: 756 of the 1,345 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Row 4 · 2026-02-12 · Tax withholding · Disposed 58 · Balance 10,149 F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $178.68 · Expires 2036-02-11 | Direct | 1,600 |
Reported balance
After 2026-02-11 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-02-11 · Grant · Acquired 1,600 · Balance 1,600 F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. |
Filing footnotes · ownership attribution and instrument terms
F1: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
F2: Represents the vesting of performance stock units (includes 22 dividend equivalent shares) for the 2023-2025 performance period.
F3: 756 of the 1,345 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting.
F4: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025).
F5: Options vest 20% Year 1, 40% Year 2, and 40% Year 3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2026 Filed Feb 14, 2026 00:11 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 58 | $177.49 | $10,294.42 |
DisclosureSEC source: 0001140361-26-005544 · form4.xml · nonDerivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,149 F4 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/12/2025). Read SEC document |
| February 11, 2026 Filed Feb 14, 2026 00:11 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,600 | $0.00 Strike: $178.68 | $0.00 |
DisclosureSEC source: 0001140361-26-005544 · form4.xml · derivative · entry 5 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2036-02-11 F5 · derivative.exercise_date: Options vest 20% Year 1, 40% Year 2, and 40% Year 3. Read SEC document |
| February 11, 2026 Filed Feb 14, 2026 00:11 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 756 | $178.68 | $135,082.08 |
DisclosureSEC source: 0001140361-26-005544 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,207 F3 · shares: 756 of the 1,345 performance stock units that vested on February 11, 2026 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 11, 2026 Filed Feb 14, 2026 00:11 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,345 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005544 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,963 F2 · shares: Represents the vesting of performance stock units (includes 22 dividend equivalent shares) for the 2023-2025 performance period. Read SEC document |
| February 11, 2026 Filed Feb 14, 2026 00:11 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 430 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-26-005544 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,618 F1 · shares: Ownership of restricted stock vests in Reporting Person over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2026 Filed Feb 10, 2026 21:28 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 258 | $173.16 | $44,675.28 |
DisclosureSEC source: 0001140361-26-004614 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,188 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/8/2023). Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option · Derivative | 6,000 | $0.00 Strike: $60.85 | $0.00 |
DisclosureSEC source: 0001140361-25-044551 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 1,765 | $153.80 | $271,463.88 |
DisclosureSEC source: 0001140361-25-044551 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,446 F3 · price: This transaction was executed in multiple sales ranging from $153.6900 to $154.0600 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 4,235 | $153.07 | $648,258.65 |
DisclosureSEC source: 0001140361-25-044551 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,211 F2 · price: This transaction was executed in multiple sales ranging from $152.6500 to $153.6100 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:23 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 6,000 | $60.85 | $365,100.00 |
DisclosureSEC source: 0001140361-25-044551 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,446 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 964 | $163.14 | $157,266.96 |
DisclosureSEC source: 0001140361-25-004920 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,446 F3 · shares: 964 of the 1,718 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Feb 14, 2025 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004920 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,410 F2 · shares: Represents the vesting of performance stock units (includes 29 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 23:11 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 964 | $163.14 | $157,266.96 |
DisclosureSEC source: 0001140361-25-013567 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,446 F3 · shares: 964 of the 1,718 performance stock units that vested on February 13, 2025 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 13, 2025 Filed Apr 11, 2025 23:11 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013567 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,410 F2 · shares: Represents the vesting of performance stock units (includes 29 dividend equivalent shares) for the 2022-2024 performance period. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,400 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-004920 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 1,400 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 22:59 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-004920 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,692 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 23:11 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,400 | $0.00 Strike: $159.18 | $0.00 |
DisclosureSEC source: 0001140361-25-013567 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,400 Underlying: Common Stock · 1,400 shares Expires 2035-02-12 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 12, 2025 Filed Apr 11, 2025 23:11 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 410 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-25-013567 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,692 F1 · shares: Ownership of restricted stock vests in Reporting Person ratably over a 3-year period (25% on the first anniversary of the grant date, 25% on the second anniversary of the grant date, and 50% on the third anniversary of the grant date), subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 23:18 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 258 | $159.39 | $41,122.62 |
DisclosureSEC source: 0001140361-25-004095 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,282 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/10/2022). Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 22:08 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 3,750 | $0.00 Strike: $60.85 | $0.00 |
DisclosureSEC source: 0001140361-24-035583 · form4.xml · derivative · entry 5 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,750 shares Expires 2026-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Stock options that vested 20% on February 23, 2017, 40% on February 23, 2018, and 40% on February 23, 2019, and are exercisable. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 22:08 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Options (right to buy) · Derivative | 4,000 | $0.00 Strike: $58.52 | $0.00 |
DisclosureSEC source: 0001140361-24-035583 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 22:08 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 7,750 | $180.05 | $1,395,411.53 |
DisclosureSEC source: 0001140361-24-035583 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,540 F2 · price: This transaction was executed in multiple sales ranging from $180.0000 to $180.5300 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 22:08 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 3,750 | $60.85 | $228,187.50 |
DisclosureSEC source: 0001140361-24-035583 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,290 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 22:08 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 4,000 | $58.52 | $234,080.00 |
DisclosureSEC source: 0001140361-24-035583 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| February 11, 2024 Filed Feb 13, 2024 21:54 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 281 | $145.33 | $40,837.73 |
DisclosureSEC source: 0001140361-24-007478 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,540 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/11/2021) Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,500 | $0.00 Strike: $143.43 | $0.00 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 1,500 shares Expires 2034-02-08 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 957 | $143.43 | $137,262.51 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,821 F3 · shares: 957 of the 1,704 performance stock units that vested on February 8, 2024 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,778 F2 · shares: Represents the vesting of performance stock units (includes 27 dividend equivalent shares) for the 2021-2023 performance period. Read SEC document |
| February 08, 2024 Filed Feb 13, 2024 00:04 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 470 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-007146 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,074 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 13, 2023 Filed Feb 15, 2023 21:16 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 264 | $135.67 | $35,816.88 |
DisclosureSEC source: 0001140361-23-007252 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,604 F1 · shares: Reflects shares that were withheld to cover withholding taxes due upon vesting of restricted shares (granted on 2/13/2020). Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantStock Option · Derivative | 1,600 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · derivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 Underlying: Common Stock · 1,600 shares Expires 2033-02-08 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | Tax withholdingCommon Stock | 918 | $138.09 | $126,766.62 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,868 F3 · shares: 918 of the 1,636 performance stock units that vested on February 8, 2023 were withheld to cover tax requirement due upon vesting. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 1,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,786 F2 · shares: Represents the vesting of performance stock units (includes 24 dividend equivalent shares) for the 2020-2022 performance period. Read SEC document |
| February 08, 2023 Filed Feb 11, 2023 01:35 UTC | BALCHEM CORP BCPC · Entity 3839 | GrantCommon Stock | 460 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006117 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,150 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 1,000 | $131.12 | $131,120.70 |
DisclosureSEC source: 0001140361-22-029845 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F2 · price: This transaction was executed in multiple sales ranging from $131.00 to $131.51 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 1,000 | $58.52 | $58,520.00 |
DisclosureSEC source: 0001140361-22-029845 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 12, 2022 Filed Sep 20, 2022 20:15 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $58.52 | $0.00 |
DisclosureSEC source: 0001140361-22-034003 · form4.xml · derivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 1,000 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 2,629 | $127.01 | $333,903.77 |
DisclosureSEC source: 0001140361-22-028897 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F2 · price: This transaction was executed in multiple sales ranging from $127.00 to $127.05 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 2,629 | $50.32 | $132,291.28 |
DisclosureSEC source: 0001140361-22-028897 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| August 05, 2022 Filed Sep 20, 2022 20:15 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,629 | $0.00 Strike: $50.32 | $0.00 |
DisclosureSEC source: 0001140361-22-034002 · form4.xml · derivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,629 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options that vested 20% on February 26, 2015, 40% on February 26, 2016, and 40% on February 26, 2017, and are exercisable. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 1,371 | $127.00 | $174,120.56 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 6 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F3 · price: This transaction was executed in multiple sales ranging from $127.0000 to $127.0150 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 1,371 | $50.32 | $68,988.72 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 5 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 04, 2022 Filed Sep 20, 2022 20:16 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,371 | $0.00 Strike: $50.32 | $0.00 |
DisclosureSEC source: 0001140361-22-034001 · form4.xml · derivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629 Underlying: Common Stock · 1,371 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options that vested 20% on February 26, 2015, 40% on February 26, 2016, and 40% on February 26, 2017, and are exercisable. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 1,401 | $125.02 | $175,148.12 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F2 · price: This transaction was executed in multiple sales ranging from $125.0000 to $125.0550 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | SaleCommon Stock | 2,200 | $126.00 | $277,206.38 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,831 Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 1,000 | $58.52 | $58,520.00 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionCommon Stock | 1,200 | $38.10 | $45,720.00 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 03, 2022 Filed Sep 20, 2022 20:16 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $58.52 | $0.00 |
DisclosureSEC source: 0001140361-22-034001 · form4.xml · derivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,000 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable. Read SEC document |
| August 03, 2022 Filed Sep 20, 2022 20:16 UTC Amendment | BALCHEM CORP BCPC · Entity 3839 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $38.10 | $0.00 |
DisclosureSEC source: 0001140361-22-034001 · form4.xml · derivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options that vested 20% on February 19, 2014, 40% on February 19, 2015, and 40% on February 19, 2016, and are exercisable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.